Treating rheumatoid arthritis with tumour necrosis factor α blockade : May be a giant therapeutic leap or a small expensive step

Documenti analoghi

• Tumour necrosis factor blockade in rheumatoid arthritis
  di: Breedveld, Ferdinand C
  Pubblicazione: (2001)
• Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
  di: Coulthard, LR, et al.
  Pubblicazione: (2007)
• Persistence of interleukin 7 activity and levels on tumour necrosis factor α blockade in patients with rheumatoid arthritis
  di: van Roon, Joel A G, et al.
  Pubblicazione: (2007)
• Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
  di: Ernestam, Sofia, et al.
  Pubblicazione: (2006)
• Blockade of tumour necrosis factor α significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis
  di: Yazdani-Biuki, B, et al.
  Pubblicazione: (2005)